Gennex Laboratories: Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30 2025;2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30 2025;3. Other Business items.